Novavax Inc - Company Profile
Powered by
All the data and insights you need on Novavax Inc in one report.
- Save hours of research time and resources with
our up-to-date Novavax Inc Strategy Report
- Understand Novavax Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Novavax Inc (Novavax) is a clinical-stage vaccine company with focus on the discovery of novel vaccines spanning a broad range of infectious diseases. Focused R&D activities, technological advancements and business collaborations are its major strengths, even as a history of losses is a cause for concern. The company could capture opportunities through its regulatory approvals, market potential for seasonal influenza vaccines and increasing healthcare expenditure in the US. However, industry competition, uncertain R&D outcomes and reliance on third-party distributors could pose challenges to the company.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward